| Entity | Document Type | Tax ID |
|---|---|---|
| The National Cancer Coalition | IRS Form 990 | 76-0435022 |
| The National Cancer Coalition | Audited Financial Statements | 76-0435022 |
|
Entity: The National Cancer Coalition Document Type: IRS Form 990 Tax ID: 76-0435022 |
|
Entity: The National Cancer Coalition Document Type: Audited Financial Statements Tax ID: 76-0435022 |
CharityWatch is unable to provide a range of Top Three Salaries for this charity for the above fiscal reporting year because we lack complete salary data for the organization. Except for officers, directors, and trustees, the IRS does not require breakouts of salaries totaling less than $100,000.
For example, XYZ charity would be required to provide a breakout in its tax form of compensation to its president of $55,000, but would not be required to provide a breakout of $99,000 in compensation to its top medical researcher if that person is not also an officer, director, or trustee of the organization.
This charity reports that compensation to its officers, directors, and trustees is under $100,000 per individual. Donors who would like to view limited salary data for this organization should refer to its tax form, which may be available on the charity's web site or from a number of third-party sources. See CharityWatch's Links page for information on obtaining copies of charity tax forms.
| According to a Final Judgment and Permanent Injunction, dated March 8, 2018, in the matter of The People of the State of California v. The National Cancer Coalition, The National Cancer Coalition (NCC) will be dissolved. In a complaint filed on March 6, 2018, the California Attorney General alleged that NCC made "false and deceptive representations" related to its "vastly overvalued" in-kind pharmaceutical donations, and that NCC made misrepresentations in its fundraising solicitations about its Breast Cancer Relief Foundation "special project." As stated in the allegations against NCC: "When, as in this case, a charity unlawfully and unfairly includes inflated values for gifts in kind in its public reporting, it appears larger and more efficient than it really is, and thus more attractive to donors." [CharityWatch's treatment of in-kind donations is noted below in the last of the Analysts' Notes listed.] As part of the Final Judgment, NCC "admits that its use of U.S. market prices in valuing its pharmaceutical donations overseas violated GAAP [Generally Accepted Accounting Principles] and California law because the pharmaceuticals were restricted to use and distribution outside the U.S." One example of NCC's "vastly overvalued" pharmaceutical donation transactions included in the complaint alleges that for a shipment to Nicaragua in 2013, NCC valued the pharmaceuticals Simvastatin and Hydrochlorothiazide at $115,625 (total) using U.S. prices, a value that "was over six times the true fair market value of less than $18,500 using the applicable international prices." [NOTE: Click on the "Articles & Alerts" tab (above) for a link to the California AG's March 2018 press release about the judgment against National Cancer Coalition.] |
| According to The National Cancer Coalition (NCC) audit of September 30, 2015 (Note 12, Change in Operating Environment): "As a result of a material decline in the availability of suitable [donated] pharmaceuticals, NCC incurred a material drop in inventory, revenues and programming. The directors and management recognized these changes and have restructured NCC by reducing salaries and operating expenses. These reductions include the relocation of NCC from Raleigh, North Carolina to New Orleans, Louisiana and major reductions in officer salaries in amount that is expected to be larger than the declines [in] cash funding." [Note: NCC reported having an unrestricted asset fund balance deficit of -$51,957, according to its audited Statement of Financial Position at September 30, 2015.] |
| According to The National Cancer Coalition (NCC) tax filing for the fiscal year-ended September 30, 2015, NCC received donated in-kind drugs and medical supplies valued at $552,972 in fiscal 2015 (IRS Form 990 Schedule M). [Note: CharityWatch generally excludes the value of in-kind (non-cash) donations of goods and services from its calculations of Program % and Cost to Raise $100. More information on how grades are calculated and the treatment of in-kind donations can be found on the Our Process page.] |